Details for New Drug Application (NDA): 012674
✉ Email this page to a colleague
NDA 012674 describes HEXADROL, which is a drug marketed by Aspen Global Inc and is included in three NDAs. Additional details are available on the HEXADROL profile page.
The generic ingredient in HEXADROL is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
The generic ingredient in HEXADROL is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
Summary for 012674
| Tradename: | HEXADROL |
| Applicant: | Aspen Global Inc |
| Ingredient: | dexamethasone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 012674
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | ELIXIR;ORAL | Strength | 0.5MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
